Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 12-2000 | 09-2000 | |
| Sales | 131,278 | 119,270 | 58,554 | 0 | 0 |
| Gross Profit | 131,240 | 119,120 | 58,554 | 0 | N/A |
| Operating Income | 131,278 | 119,270 | 58,554 | 0 | N/A |
| Pre-tax Income | 131,278 | 119,270 | 58,554 | 0 | 0 |
| Net Income Continuous | -6,524 | -3,369 | 1,191 | 0 | N/A |
| Net Income Discontinuous | -806 | 0 | 0 | 0 | N/A |
| Net Income | $-7,330 | $-3,369 | $1,191 | $0 | $N/A |
| EPS Basic Total Ops | -0.87 | -0.66 | 0.27 | N/A | N/A |
| EPS Basic Continuous Ops | -0.77 | -0.66 | 0.27 | N/A | N/A |
| EPS Basic Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.87 | -0.66 | 0.27 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.77 | -0.66 | 0.27 | N/A | N/A |
| EPS Diluted Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $131,768 | $119,450 | $58,554 | $0 | $N/A |